Rashtriya Chemicals & Fertilizers Ltd
RCFRashtriya Chemicals & Fertilizers Ltd's earnings have outrun its stock. EPS grew +76.5% in a year against a −26.8% price move.
The sharpest disagreement: annual EPS moved +76.5% against a −26.8% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (49 weeks in) while the P/E sits at the 39th percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +37.0% year on year, and 165% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Rashtriya Chemicals & Fertilizers Ltd trades at ₹111, in a downtrend and 49 weeks into that stage. That is −14.1% against its own 200-day average. It sits at 0% of a 52-week range of ₹111 to ₹150. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (10 weeks and counting).
Today the stock is in a downtrend — week 49 of stage 4, confirmed. At ₹111 it trades −14.1% versus its 200-day average and sits at 0% of its 52-week range (₹111–₹150).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +198% while the NIFTY 500 moved +267% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (10 weeks and counting; last ahead the week of 2026-07-03) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Rashtriya Chemicals & Fertilizers Ltd trades at 14.8× P/E, mid-range by its own standards (39th percentile). Its long-run median P/E is 20.8×, measured across 10.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 14.8× is mid-range by its own standards (39th percentile), against a long-run median of 20.8× measured over 10.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +76.5% against a −26.8% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +8.5%/yr price move, ~−2.7%/yr came from earnings growth and ~+11.2 pp from the multiple (expanding); over 10y, of the +8.7%/yr price move, ~+9.4%/yr came from earnings growth and ~−0.7 pp from the multiple (roughly flat). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, Rashtriya Chemicals & Fertilizers Ltd was paying for profit growth of about 9.1% a year. Profit itself has compounded 9.7% a year over the past 10 years. Today the market pays 14.8× P/E, the 39th percentile of its own 11-year range.
What the two numbers say together. The multiple is unremarkable against its own past, and the growth the price is paying for is close to what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Rashtriya Chemicals & Fertilizers Ltd reads as improving on its fundamental arc. Improving — profit growth bottomed 8 quarters ago at −76.6% and has held its recovery at +56.8%, ROCE lifting at 13.1%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +9.1% | −4.8% | +17.4% | +8.4% |
| Profit | +76.4% | −23.8% | +2.1% | +9.7% |
| EPS | +76.5% | −23.8% | +2.2% | +9.7% |
| Share price | −26.8% | −4.1% | +8.5% | +8.7% |
4-Factor Sector Score
53.3/100 — rank 5 of 15 in Fertilisers · 94% evidence confidence
Rashtriya Chemicals & Fertilizers Ltd scores 53.3 out of 100 against the 15 companies it is compared with in Fertilisers, ranking 5. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 25 + 7.8 + 12.9 + 7.6 = 53.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Rashtriya Chemicals & Fertilizers Ltd reported ₹3,586 Cr of revenue in the Jun 26 quarter, +6.4% year on year. That is the 2nd straight quarter of year-on-year growth. Over 10 years it has compounded at 8.4% a year. The last full year, FY26, came in at ₹18,480 Cr. The last four reported quarters add to ₹18,696 Cr.
FY26 revenue came in at ₹18,480 Cr (+9.1% on the year), capping 10 years at 8.4% compound. The latest quarter (Jun 26) printed ₹3,586 Cr, +6.4% year on year — the 2nd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +18.3% growth against the decade's 8.4% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +17.5% over the last 4 quarters against +3.9%/yr over the last 8 — accelerating; TTM profit +56.8% vs +63.1%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Rashtriya Chemicals & Fertilizers Ltd's operating margin is 6.0% in the Jun 26 quarter, +1.3 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 3.1% to 11.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 6.0%, +1.3 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 3.1%–11.0%.
Why the margin moved: operating margin went +1.4 pp year on year while gross margin went +0.4 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Rashtriya Chemicals & Fertilizers Ltd earned ₹74.0 Cr of net profit in the Jun 26 quarter, +37.0% year on year. It is the 5th consecutive quarter of growth. Full-year FY26 profit was ₹427 Cr. The 10-year compound rate is 9.7%. That is 2.1% of the quarter's revenue. The same quarter a year earlier earned ₹54.0 Cr.
Jun 26 profit was ₹74.0 Cr, +37.0% year on year — the 5th consecutive quarter of growth. On the full year, FY26 printed ₹427 Cr (+76.4%), and the 10-year compound rate is 9.7%.
Why profit moved: revenue contributed +6.4% and the margin +1.3 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +57.7% vs revenue +18.3%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 165% of Rashtriya Chemicals & Fertilizers Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹−471 Cr of operating cash against ₹427 Cr of profit. After ₹912 Cr of capital spending, ₹−1,383 Cr was left as free cash.
FY26: operating cash of ₹−471 Cr against reported profit of ₹427 Cr, leaving free cash of ₹−1,383 Cr after ₹912 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 165% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 165%: the cash cycle stretched 39 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 2.7× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Rashtriya Chemicals & Fertilizers Ltd's cash conversion cycle runs 94 days in FY26, up from 55 days in FY21. Capital spending ran ₹2,138 Cr over the last 3 years. At FY26 sales of ₹18,480 Cr each day of that cycle holds about ₹50.6 Cr, so roughly ₹4,759 Cr sits inside the business at any moment.
FY26: debtors at 93 days, inventory at 52 days — roughly 1.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 94 days, looser than FY21's 55.
The full loop: cash goes out to suppliers and production on day 0; stock waits 52 days to sell; customers pay about 93 days after that; and suppliers themselves are paid at 50 days — netting out to the 94-day cycle.
In money terms: at FY26 sales of ₹18,480 Cr, each day of the cycle holds about ₹50.6 Cr — so the 94-day loop keeps roughly ₹4,759 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹2,138 Cr over the last 3 fiscal years against ₹788 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹810 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Rashtriya Chemicals & Fertilizers Ltd earns a ROCE of 10% in FY26. That is up from a trough of 4% in FY18. Return on invested capital clears the cost of that capital by −6.6 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 2.3% net margin on 1.11× asset turns.
FY26 ROCE is 10%, recovered from a FY18 trough of 4% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 2.3% net margin × 1.11× asset turns × 3.26× balance-sheet leverage ≈ 8.3% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 5.4% − 12.0% = a −6.6 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Rashtriya Chemicals & Fertilizers Ltd carries total debt of ₹4,128 Cr against shareholder equity of ₹5,121 Cr as of Mar 26, a debt-to-equity of 0.81. On the annual view that ratio went from 0.77 in FY22 to 0.81 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹4,128 Cr against shareholder equity of ₹5,121 Cr — a debt-to-equity of 0.81. On the annual view, debt-to-equity went from 0.77 (FY22) to 0.81 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Rashtriya Chemicals & Fertilizers Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved +0.0 points over the same window, to 2.4%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +0.0 points over 8 quarters to 75.0%; Foreign institutions: +0.0 points over 8 quarters to 2.4%; Domestic institutions: +0.0 points over 8 quarters to 0.3%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Rashtriya Chemicals & Fertilizers Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Krishana Phoschem LtdKRISHANA | 79.8/100Favorable setup100% evidence | LEADER | 29.8/35 Revenue 73.3% · PAT 92.2% · OPM change 0 pp 100% evidence | 19.0/25 ROCE 27.2% · OPM 17% 100% evidence | 12.1/20 P/E 28.2× · PEG 0.58 100% evidence | 18.9/20 RS sector 43.9% · RS bench 47% · 1Y 58.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 29.8 + 19 + 12.1 + 18.9 = 79.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Gujarat Narmada Valley Fertilizers & Chemicals LtdGNFC | 71.9/100Favorable setup100% evidence | LEADER | 25.3/35 Revenue 12.6% · PAT 84.5% · OPM change 16.1 pp 100% evidence | 13.4/25 ROCE 12% · OPM 18% 100% evidence | 15.5/20 P/E 8× · PEG 0.27 100% evidence | 17.7/20 RS sector 12.6% · RS bench 15.2% · 1Y 11.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 25.3 + 13.4 + 15.5 + 17.7 = 71.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Madhya Bharat Agro Products LtdMBAPL | 64.1/100Mixed-positive evidence100% evidence | LEADER | 25.0/35 Revenue 47.6% · PAT 100% · OPM change 2 pp 100% evidence | 16.1/25 ROCE 19.3% · OPM 16% 100% evidence | 3.0/20 P/E 45.5× · PEG 2.04 100% evidence | 20.0/20 RS sector 50.9% · RS bench 54.6% · 1Y 93.3%12 of 12 weeks ahead 100% evidence |
| Exact sum: 25 + 16.1 + 3 + 20 = 64.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Chambal Fertilisers & Chemicals LtdCHAMBLFERT | 59.7/100Mixed-positive evidence100% evidence | ASLEEP | 17.9/35 Revenue 15.6% · PAT 10.2% · OPM change 3 pp 100% evidence | 19.3/25 ROCE 25.2% · OPM 16% 100% evidence | 17.2/20 P/E 8.7× · PEG 0.52 100% evidence | 5.3/20 RS sector -9.2% · RS bench -7% · 1Y -24.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 19.3 + 17.2 + 5.3 = 59.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Rashtriya Chemicals & Fertilizers Ltdthis pageRCF | 53.3/100Mixed-positive evidence94% evidence | ASLEEP | 25.0/35 Revenue 17.5% · PAT 56.8% · OPM change 1.3 pp 100% evidence | 7.8/25 ROCE 10.4% · OPM 6% 100% evidence | 12.9/20 P/E 14.8× · PEG 0.9 100% evidence | 7.6/20 RS sector -3.1% · RS bench -14.8% · 1Y -29.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 25 + 7.8 + 12.9 + 7.6 = 53.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Khaitan Chemicals & Fertilizers LtdKHAICHEM | 50.5/100Mixed-positive evidence74% evidence | BASING | 21.6/35 Revenue 19.9% · PAT 32.5% · OPM change -3 pp 95% evidence | 15.6/25 ROCE 18.5% · OPM 11% 95% evidence | 10.3/20 P/E 9× · PEG — 15% evidence | 3.0/20 RS sector -31.3% · RS bench -20.8% · 1Y -56.5%1 of 10 weeks ahead 70% evidence |
| Exact sum: 21.6 + 15.6 + 10.3 + 3 = 50.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Paradeep Phosphates LtdPARADEEP | 49.2/100Mixed-negative evidence69% evidence | BREAKING OUT | 18.0/35 Revenue 28.1% · PAT 12.6% · OPM change -1 pp 95% evidence | 13.2/25 ROCE 15.4% · OPM 12% 76% evidence | 9.4/20 P/E 14.9× · PEG — 15% evidence | 8.6/20 RS sector -12.4% · RS bench 10.4% · 1Y -22.4%9 of 10 weeks ahead 70% evidence |
| Exact sum: 18 + 13.2 + 9.4 + 8.6 = 49.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Zuari Agro Chemicals LtdZUARI | 48.3/100Mixed-negative evidence87% evidence | TURNING | 17.3/35 Revenue -44% · PAT 100% · OPM change -1 pp 95% evidence | 10.5/25 ROCE 16.4% · OPM 10% 95% evidence | 14.6/20 P/E 3× · PEG — 50% evidence | 5.9/20 RS sector -11.5% · RS bench -9.5% · 1Y -23.7%3 of 12 weeks ahead 100% evidence |
| Exact sum: 17.3 + 10.5 + 14.6 + 5.9 = 48.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Gujarat State Fertilizers & Chemicals LtdGSFC | 47.7/100Mixed-negative evidence94% evidence | BASING | 18.4/35 Revenue 29.2% · PAT 7.8% · OPM change -3 pp 100% evidence | 6.0/25 ROCE 7.2% · OPM 6% 100% evidence | 15.8/20 P/E 9× · PEG 0.3 100% evidence | 7.5/20 RS sector -5.5% · RS bench -8.1% · 1Y -27.1%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18.4 + 6 + 15.8 + 7.5 = 47.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Southern Petrochemicals Industries Corporation LtdSPIC | 46.2/100Mixed-negative evidence80% evidence | TURNING | 11.2/35 Revenue -2.9% · PAT 28.3% · OPM change -5 pp 95% evidence | 14.4/25 ROCE 16.8% · OPM 7% 95% evidence | 11.3/20 P/E 6.9× · PEG — 15% evidence | 9.3/20 RS sector -8.1% · RS bench -6.2% · 1Y -40.4%2 of 12 weeks ahead 100% evidence |
| Exact sum: 11.2 + 14.4 + 11.3 + 9.3 = 46.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Deepak Fertilisers & Petrochemicals Corp LtdDEEPAKFERT | 45.7/100Mixed-negative evidence100% evidence | ASLEEP | 13.5/35 Revenue 13.6% · PAT -0.5% · OPM change 7 pp 100% evidence | 12.1/25 ROCE 11.4% · OPM 26% 100% evidence | 11.1/20 P/E 16.9× · PEG 0.57 100% evidence | 9.0/20 RS sector -0.5% · RS bench 1.4% · 1Y -5.9%8 of 12 weeks ahead 100% evidence |
| Exact sum: 13.5 + 12.1 + 11.1 + 9 = 45.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Coromandel International LtdCOROMANDEL | 45.5/100Mixed-negative evidence94% evidence | FADING | 14.0/35 Revenue 23.5% · PAT -20.9% · OPM change -2 pp 100% evidence | 17.2/25 ROCE 22% · OPM 9% 100% evidence | 1.9/20 P/E 30.5× · PEG 2.69 100% evidence | 12.4/20 RS sector 5% · RS bench -7.1% · 1Y -14.6%4 of 10 weeks ahead 70% evidence |
| Exact sum: 14 + 17.2 + 1.9 + 12.4 = 45.5 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 13National Fertilizer LtdNFL | 40.9/100Mixed-negative evidence84% evidence | ASLEEP | 24.5/35 Revenue 23.3% · PAT 100% · OPM change 3.7 pp 74% evidence | 4.1/25 ROCE 9.1% · OPM 6% 100% evidence | 10.0/20 P/E 9.2× · PEG 1.39 65% evidence | 2.3/20 RS sector -15% · RS bench -13% · 1Y -30.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 4.1 + 10 + 2.3 = 40.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -15% and the one-year return is -30.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 14Madras Fertilizers LtdMADRASFERT | 29.8/100Adverse evidence74% evidence | ASLEEP | 4.5/35 Revenue -4.5% · PAT 4.3% · OPM change -4 pp 95% evidence | 10.9/25 ROCE 14.8% · OPM 6% 95% evidence | 9.9/20 P/E 12.8× · PEG — 15% evidence | 4.5/20 RS sector -14.4% · RS bench -12.7% · 1Y -33.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 4.5 + 10.9 + 9.9 + 4.5 = 29.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Fertilizers & Chemicals Travancore LtdFACT | 26.9/100Adverse evidence75% evidence | ASLEEP | 9.0/35 Revenue 32% · PAT -80% · OPM change -4.7 pp 100% evidence | 3.9/25 ROCE 4.9% · OPM -2.4% 80% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.0/20 RS sector -9.4% · RS bench -7.3% · 1Y -21.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 9 + 3.9 + 10 + 4 = 26.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Rashtriya Chemicals & Fertilizers Ltd's share price today?
Rashtriya Chemicals & Fertilizers Ltd trades at ₹111, −26.8% over the past year. The company is valued at ₹6,149 Cr. The stock sits at the very bottom of its 52-week range (₹111–₹150), −14.1% versus its 200-day average. On the tape, the price is in a downtrend, 49 weeks in. — as of 11 September 2026.
What were Rashtriya Chemicals & Fertilizers Ltd's latest quarterly results?
Rashtriya Chemicals & Fertilizers Ltd reported revenue of ₹3,586 Cr and net profit of ₹74.0 Cr for the Jun 26 quarter. Revenue rose 6.4% and profit rose 37.0% year on year. Earnings per share were ₹1.33. The operating margin was 6.0%, 1.3 pp higher than a year earlier. — as of 11 September 2026.
What is Rashtriya Chemicals & Fertilizers Ltd's revenue?
Rashtriya Chemicals & Fertilizers Ltd reported revenue of ₹3,586 Cr in the Jun 26 quarter, +6.4% year on year. For the full FY26 fiscal year, revenue was ₹18,480 Cr (+9.1%). Over the last 10 years revenue compounded at 8.4% a year. — as of 11 September 2026.
What is Rashtriya Chemicals & Fertilizers Ltd's profit?
Rashtriya Chemicals & Fertilizers Ltd earned ₹74.0 Cr of net profit in the Jun 26 quarter, +37.0% year on year — the 5th straight quarter of growth. Full-year FY26 profit was ₹427 Cr. The operating margin ran 6.0% in the latest quarter. — as of 11 September 2026.
What is Rashtriya Chemicals & Fertilizers Ltd's market cap?
Rashtriya Chemicals & Fertilizers Ltd's market capitalisation is ₹6,149 Cr at a share price of ₹111. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Rashtriya Chemicals & Fertilizers Ltd's P/E ratio?
Rashtriya Chemicals & Fertilizers Ltd trades at a P/E of 14.8×, at the 39th percentile of its own 11-year range, against a long-run median of 20.8×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Rashtriya Chemicals & Fertilizers Ltd pay a dividend?
Yes — Rashtriya Chemicals & Fertilizers Ltd's dividend payout was 30% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Rashtriya Chemicals & Fertilizers Ltd overvalued?
On its own history, Rashtriya Chemicals & Fertilizers Ltd looks mid-range: its P/E of 14.8× sits at the 39th percentile of its 11-year range (long-run median 20.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Rashtriya Chemicals & Fertilizers Ltd growing?
Yes — Rashtriya Chemicals & Fertilizers Ltd is growing: latest-quarter revenue +6.4% year on year, profit +37.0%, and the margin +1.3 pp at 6.0%. The 10-year compound rates are 8.4% (revenue) and 9.7% (profit). The earnings engine currently reads: improving — as of 11 September 2026.
How is Rashtriya Chemicals & Fertilizers Ltd performing?
Rashtriya Chemicals & Fertilizers Ltd is in a downtrend, 49 weeks in. Its latest quarter's revenue rose 6.4% and profit rose 37.0% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 10 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Rashtriya Chemicals & Fertilizers Ltd in?
Improving — profit growth bottomed 8 quarters ago at −76.6% and has held its recovery at +56.8%, ROCE lifting at 13.1%. The read comes from the last 12 quarters of growth (revenue growth +17.5% latest, profit growth +56.8% latest, eps growth +56.2% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Rashtriya Chemicals & Fertilizers Ltd in an uptrend?
No — the price is in a downtrend (week 49 of stage 4), trading −14.1% versus its 200-day average and at the very bottom of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Rashtriya Chemicals & Fertilizers Ltd beating the market?
Not lately — on a trailing-13-week view Rashtriya Chemicals & Fertilizers Ltd is currently behind the NIFTY 500 (10 weeks and counting; last ahead the week of 2026-07-03), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +198% against the NIFTY 500's +267% — behind the index over the full window. — as of 11 September 2026.
Will Rashtriya Chemicals & Fertilizers Ltd's share price go up?
This page publishes no price forecast for Rashtriya Chemicals & Fertilizers Ltd. What it measures instead: the share price is ₹111, the price is in a downtrend 49 weeks in. Its P/E of 14.8× sits at the 39th percentile of its own 11-year range. — as of 11 September 2026.
Who owns Rashtriya Chemicals & Fertilizers Ltd?
Promoters hold 75.0% of Rashtriya Chemicals & Fertilizers Ltd, foreign institutions 2.4%, domestic institutions 0.3% and the public 22.3% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 11 September 2026.
Does Rashtriya Chemicals & Fertilizers Ltd have too much debt?
It is moderate — Rashtriya Chemicals & Fertilizers Ltd's debt-to-equity is 0.81, and operating profit covers the interest bill 3×. FY26 borrowings were ₹4,128 Cr against equity of ₹5,122 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is Rashtriya Chemicals & Fertilizers Ltd's capex?
Rashtriya Chemicals & Fertilizers Ltd spent ₹2,138 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹912 Cr, with ₹810 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Rashtriya Chemicals & Fertilizers Ltd's cash flow?
Rashtriya Chemicals & Fertilizers Ltd consumed ₹471 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−1,383 Cr). Operating cash was negative while the company reported a profit of ₹427 Cr. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Rashtriya Chemicals & Fertilizers Ltd's profit real cash?
Yes — over the last 3 fiscal years, 165% of Rashtriya Chemicals & Fertilizers Ltd's reported profit arrived as operating cash. Though the latest year ran at -110% — the trend is the thing to watch. In FY26, operating cash was ₹−471 Cr against reported profit of ₹427 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Rashtriya Chemicals & Fertilizers Ltd in its business cycle?
Rashtriya Chemicals & Fertilizers Ltd's FY26 operating margin was 5.0%, against a 13-year band of 3.1%–11.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 6.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Rashtriya Chemicals & Fertilizers Ltd's price assume?
At its price on 13 June 2026, Rashtriya Chemicals & Fertilizers Ltd was priced for profit growth of about 9.1% a year. Profit itself has compounded 9.7% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Rashtriya Chemicals & Fertilizers Ltd story?
The sharpest disagreement: annual EPS moved +76.5% against a −26.8% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Rashtriya Chemicals & Fertilizers Ltd a stock worth studying right now?
This is not investment advice. The machine read: Rashtriya Chemicals & Fertilizers Ltd's earnings have outrun its stock. EPS grew +76.5% in a year against a −26.8% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!